Lucienne Ide: RPM can enable better access and enhance the standard of care to those who have the hardest time receiving it

January 17, 2022 00:22:12
Lucienne Ide: RPM can enable better access and enhance the standard of care to those who have the hardest time receiving it
The Big Unlock
Lucienne Ide: RPM can enable better access and enhance the standard of care to those who have the hardest time receiving it

Jan 17 2022 | 00:22:12

/

Show Notes

In this podcast, Dr. Lucienne Ide, Founder and CEO of Rimidi, acknowledges the rapidly evolving healthcare market and discusses her passion for making healthcare scalable and better for all stakeholders by leveraging the right tools, insights, and analytics needed at the points of care. Rimidi is a clinical management platform designed to optimize clinical workflows.

Dr. Ide wears many hats – an executive, a physician-scientist, health IT enthusiast, entrepreneur, and problem-solver. She states why sustainable, innovative, and impactful solutions are crucial for chronic disease management and share some unique perspectives on how technology and policy need to align to extend care to those who have the hardest time receiving it. She also acknowledges reimbursement as one of the barriers in enabling digital health models at the point of care. Take a listen.

Other Episodes

Episode 0

June 30, 2025 00:27:29
Episode Cover

Designing AI-Native Healthcare with Innovation, Automation, and Responsible AI.

 The Big Unlock Podcast · Designing AI-Native Healthcare with Innovation, Automation, and Responsible AI. – Podcast with Sara Vaezy In this episode, Sara...

Listen

Episode 0

January 24, 2021 00:35:34
Episode Cover

<h1>Vivian S. Lee: It's vital for tech firms to earn and maintain the trust of people we care for</h1>

In this episode, Dr. Lee shares some examples of how the intersection between traditional healthcare and technology can be beneficial to improve healthcare outcomes...

Listen

Episode 0

March 03, 2021 00:24:38
Episode Cover

Casey Ross: The pace of innovation and development of AI tools is outrunning the FDA and other regulators' ability to stay on top of AI innovations

In this episode, Casey Ross, National Technology Correspondent at Stat News, discusses his recently published report on FDA-approved AI-enabled tools. These are Software as...

Listen